Literature DB >> 812551

Effect of bile salts on lactosylceramide beta-galactosidase activities in human brain, liver and cultured skin fibroblasts.

M Sattler, C Clark.   

Abstract

The effect of bile salts on the hydrolysis of lactosylcermide by human beta-galactosidases in vitro was studied using cultured skin fibroblasts, liver and brain tissue. The evidence for two distinct enzymes that can catalyze the hydrolysis of lactosylceramide was observed when the bile salt was changed from pure sodium taurocholate to either crude taurocholate, or pure glycodeoxycholate, taurodeoxycholate or taurochenodeoxycholate. Tissues from patients with Krabbe's disease were found to be deficient in lactosylceramide beta-galactosidase activity (lactosylceramidase I) when pure taurocholate was used in the assay. When crude taurocholate was used in the assay, the Krabbe patients appeared to have normal activity for this enzyme. In place of crude taurocholate the pure salts of glycodeoxycholate, taurodeoxycholate and taurochenodeoxycholate worked even better to stimulate the second lactosylceramide beta-galactosidase activity and GM1 gangliosidosis patients exhibiting little if any activity. Therefore, lactosylcermidase I is stimulated by crude taurocholate or pure glycodeoxycholate, taurodeoxycholate and taurochenodeoxycholate. The use of pure bile salts to assay lactosylceramidase I and II will result in better reproducibility for these enzyme activities between laboratories.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 812551     DOI: 10.1016/0005-2760(75)90025-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Purified human liver acid beta-D-galactosidases possessing activity towards G(M1)-ganglioside and lactosylceramide.

Authors:  A L Miller; R G Frost; J S O'Brien
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

2.  Enzymic hydrolysis of sphingomyelin in the presence of bile salts.

Authors:  S Yedgar; S Gatt
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

3.  The interrelations between high- and low-molecular weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase.

Authors:  Y Ben-Yoseph; M Hungerford; H L Nadler
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

4.  Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis.

Authors:  S Chakraborty; M A Rafi; D A Wenger
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

5.  Antenatal diagnosis of Krabbe's leucodystrophy: enzymatic and morphological confirmation in an affected fetus.

Authors:  D F Farrell; S M Sumi; C R Scott; G Rice
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-01       Impact factor: 10.154

6.  Binding of human liver hydrolases by immobilized lectins.

Authors:  M B Fiddler; Y Ben-Yoseph; H L Nadler
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

7.  The nature of mutation in Krabbe disease.

Authors:  Y Ben-Yoseph; M Hungerford; H L Nadler
Journal:  Am J Hum Genet       Date:  1978-11       Impact factor: 11.025

8.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.